Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseLeucoreduction of blood components: an effective way to increase blood safety?Anemia and blood transfusions in critically ill patientsTransfusion-related acute lung injury; clinical perspectivesTransfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusionAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury.Transfusion-related acute lung injury and potential risk factors among the inpatient US elderly as recorded in Medicare claims data, during 2007 through 2011.Ventilator associated pneumonia and transfusion, is there really an association? (the NAVTRA study).Acute lung injury after blood transfusion in mechanically ventilated patients.Interstitial lung disease (ILD) and severe ITP.A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura.Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.Platelet transfusions for patients with haematological malignancies: who needs them?Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivoThe association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationAcute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery.Contribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery.Acute lung injury after platelet transfusion in a patient with dengue feverPostresectional lung injury in thoracic surgery pre and intraoperative risk factors: a retrospective clinical study of a hundred forty-three casesThe role of neutrophils in the pathogenesis of transfusion-related acute lung injury.Transfusion-related acute lung injury after transfusion of maternal blood: a case-control study.Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcomeExperimental models of transfusion-related acute lung injury.Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasmaPulmonary transfusion reactions.Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff.
P2860
Q24186359-5F70CE05-26C1-42EB-A044-5665EAADAE4FQ24186913-F96387A4-5EC1-4B49-BC12-8B93AC958AB3Q24187258-BD255AC5-5339-4BD8-B0FE-39581968470EQ24187460-CD58F43C-C26B-4358-B6F4-51112CA1ACB6Q24187751-C306B356-5809-484F-8560-707BD1B8335FQ24198288-2E072DF8-2F39-4315-8F75-D777892E1E01Q24198774-222EAA60-9CD6-47C3-838E-8FCDDF4BF216Q24198795-55E87C78-7560-4996-A4DB-83F365A5BADEQ24198832-D7F6E964-1DF3-4789-913F-1BAC11A41F7EQ24200508-09EC5FA3-4005-42C4-B3CE-C5B980A1CB63Q24201453-1860DDBE-2B04-4E68-A082-5054F76BE104Q26771857-DD88766A-2555-47E0-B602-66389DB5A952Q26822895-DBF2D224-3ECE-41C0-AC93-65419A398D5BQ28081342-516E38C6-3A68-4892-9493-CC460B387E94Q28254823-096F9D2F-4A9B-439D-BEC9-DB517B8BB212Q30248355-8AD3ECFD-EF1B-4BCC-AFD4-FCD2CD2DD8F8Q30300632-B5E3953B-BCED-4409-AC87-FE666DDE5FC0Q30786714-DCE83D53-354C-48BD-8268-DA8A52851CD9Q30820415-94C00C29-979F-429B-8710-6E3AEF40A326Q33362738-F54922BA-B4BC-440C-84C1-BB6AE3D6CE77Q33374583-791C0ACF-813F-4E5A-88B8-14C8F67ACA7CQ33378563-5BF27E5B-434A-45A2-B295-1B0AA7F1AA3FQ33386526-00B0C93F-BEA2-4FB0-8DB8-B1BA162B49B3Q33395509-BB6DB812-84DF-43DC-AC11-F1E04DA7DCCAQ33415740-A73F1E49-EAC9-468D-AC65-46F164F37623Q33697274-A49B49AB-560E-41E1-8749-3ACBEA58982DQ33760834-58CE458E-89B7-4478-AD80-6685C409C528Q33815051-21653EFF-9409-40B3-9D42-E35105620D00Q33901301-17001635-519E-4AE9-ACFD-FBE2F5E70FEEQ33953460-66C895B8-1F28-4649-9165-B0B7CA11ADAEQ34073107-5A264FCA-8DEC-4CA6-B802-029B584C10C4Q34114064-8F87FFB0-EAC6-4C22-A544-27A821A08722Q34118409-BA5B9D6B-62AD-4ED1-B3C9-EC19AEB273C1Q34242373-A010A6EC-DEA5-4D43-BE69-08D3C3156C12Q34434386-6496E842-3420-456B-B173-2D93E8369FECQ34447443-E4048CA7-F7B4-4AD5-8A43-1221924B76CCQ34531815-44EC51D4-2D6F-4D58-AA72-9032AD41536AQ34679401-DA3505BF-819D-42CF-A0D4-1345C3B34A8FQ34790939-9B8AE380-C83C-47CD-BB27-94076D3AA09AQ34949888-E6C4207B-4EDF-4E94-A838-5B4B6FF0A150
P2860
Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Transfusion-related acute lung ...... analysis of etiologic factors.
@en
Transfusion-related acute lung ...... analysis of etiologic factors.
@nl
type
label
Transfusion-related acute lung ...... analysis of etiologic factors.
@en
Transfusion-related acute lung ...... analysis of etiologic factors.
@nl
prefLabel
Transfusion-related acute lung ...... analysis of etiologic factors.
@en
Transfusion-related acute lung ...... analysis of etiologic factors.
@nl
P2093
P1433
P1476
Transfusion-related acute lung ...... analysis of etiologic factors.
@en
P2093
Christopher C Silliman
Daniel R Ambruso
Gwen Clarke
Linda Podlosky
Lynn K Boshkov
William O Dickey
Zahra Mehdizadehkashi
P304
P356
10.1182/BLOOD-2002-03-0958
P407
P50
P577
2002-09-05T00:00:00Z